Vaccines Market Research Reports & Industry Analysis
Because of the large number of deadly diseases that have been eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements of the 20th century. Key issues in the global vaccine market today include unequal access to vaccines, supply chain disruptions, the use of vaccines to prevent pandemics and address bioterrorism, technological innovations, and vaccine hesitancy. Learn more about this critical field with the comprehensive selection of vaccine market research reports available on MarketResearch.com.
New Vaccines Market Data and Insights
- Find data on vaccine market size segmented by region, technology, distribution channel, type, route of administration, and disease.
- Gain a deep understanding of vaccine industry dynamics, market structure, growth outlook, and competitive landscape.
- Learn about influential government initiatives and new vaccination technologies that have highly promising results.
Your Source for Expert Data and Analysis
MarketResearch.com is a trusted research partner, backed by over two decades of experience. Our clients include top investment banks, management consulting firms, and leading multinational companies within the Fortune 500. Our team of research specialists is dedicated to guiding you at every step, ensuring you have the resources and insights you need to answer your toughest research questions. Browse our full list of vaccines industry reports today.
Vaccines Industry Research & Market Reports
-
H1N1 Vaccines
... CAGR of 5.4% over the analysis period 2024-2030. Intramuscular Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Pediatric Drugs and Vaccines
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Conjugate Technology, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$52.0 Billion by the ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Biodefense
... 4.2% over the analysis period 2024-2030. Anthrax, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in ... Read More
-
Veterinary Vaccines
... CAGR of 5.6% over the analysis period 2024-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$4.7 Billion by the end of the analysis ... Read More
-
Human Vaccines
... CAGR of 7.3% over the analysis period 2024-2030. Intramuscular & Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by the end of ... Read More
-
Tetanus Toxoid Vaccine
... at a CAGR of 2.6% over the analysis period 2024-2030. Tetanus, Diphtheria, and Pertussis (Tdap) Vaccine, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion ... Read More
-
Cancer Vaccines
... CAGR of 9.3% over the analysis period 2024-2030. Preventive Vaccine, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$7.6 Billion by the end of the analysis ... Read More
-
Preventable Vaccines
... CAGR of 1.1% over the analysis period 2024-2030. Live / Attenuated Vaccines, one of the segments analyzed in the report, is expected to record a 1.2% CAGR and reach US$34.1 Billion by the end of ... Read More
-
Vaccine Delivery Devices
... at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Vaccine Contract Manufacturing
... at a CAGR of 7.4% over the analysis period 2024-2030. Attenuated Vaccine, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
... products from the developing countries is mainly responsible for the growth of poultry medicine/pharmaceuticals market as it results in increased poultry farming practices. The rise in illnesses in poultry, especially Newcastle disease and Coccidiosis, leads ... Read More
-
Global Autogenous Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... 2024 and is forecast to a readjusted size of USD 625 million by 2031 with a CAGR of 4.3% during review period. Autogenous vaccines, also called autologous vaccines, autovaccines, “self” or custom vaccines, are vaccines, ... Read More
-
Pediatric Vaccine Global Market Opportunities And Strategies To 2033
... Pneumococcal Disease; Influenza; Measles, Mumps And RubellaCovering: Merck & Co.Inc.; SANOFI S.A.; Pfizer, Inc.; Seqirus (CSL Limited); GlaxoSmithKline plc. Pediatric Vaccine Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the ... Read More
-
Influenza Vaccines Global Market Opportunities And Strategies To 2033
... And Institutional Supply5) By Age Group: Pediatric; AdultCovering: Sanofi SA; Seqirus (CSL Limited); GlaxoSmithKline Plc; Daiichi Sankyo Co Ltd; Pfizer Inc Influenza Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company ... Read More
-
Global Foot and Mouth Disease (FMD) Vaccines Competitive Landscape Professional Research Report 2025
... goats. The FMD virus can lead to significant economic losses in the livestock industry due to decreased milk production, reduced meat quality, and trade restrictions imposed on affected regions. FMD vaccines are crucial tools in ... Read More
-
Global Hepatitis B Vaccines Competitive Landscape Professional Research Report 2025
... The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother ... Read More
-
Vaccine Storage Equipment Market by Product (Refrigerator (Large & Small Capacity)), Freezer ((Low & Ultra-Low Temperature Freezer)), Vaccine Carrier/Cold Box, Monitoring Device ((Temperature Monitoring & Alarm)), Type, End User - Global Forecast to 2029
... global Vaccine storage equipment market is projected to reach USD 1.21 billion by 2029 from USD 0.86 billion in 2024, at a CAGR of 7.2% during the forecast period. This is due to increasing need ... Read More
-
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
... 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major ... Read More
-
Global Dengue Vaccines Competitive Landscape Professional Research Report 2025
... Aedes albopictus. The vaccines are designed to stimulate the immune system to produce antibodies against the dengue virus, preventing or reducing the severity of the infection if a vaccinated person is exposed to the virus. ... Read More
-
Global Autogenous Vaccines Competitive Landscape Professional Research Report 2025
... the affected animals. These vaccines are prepared by collecting samples from the animals and identifying the specific pathogens responsible for the disease or infection. The vaccines are then developed by growing the pathogens in a ... Read More
-
Global Autogenous Vaccines Market Growth 2025-2031
... CAGR of 4.6% from 2025 to 2031. Autogenous vaccines, also called autologous vaccines, autovaccines, “self” or custom vaccines, are vaccines, which prepared by isolation and destruction of microorganisms in infected individuals and used to provide ... Read More
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End user (Hospitals, Clinics) - Global Forecast to 2029
... projected to reach USD 13.33 billion by 2029, from USD 9.39 billion in 2024, at a CAGR of 6.1%.” during the forecast period. The growing awareness of animal health, along with the rising pet population ... Read More
-
Single Use Assemblies Market by Product (Bag (2D, 3D), Filtration, Bottle, Mixing, Tubing Assemblies), Solution (Customized, Standard), Modality (mAbs, Vaccines, CGT), Application (Filtration, Cell Culture, Storage, Transfer) - Global Forecasts to 2029
... market is expected to grow to USD 4.89 billion by 2029, up from USD 2.63 billion in 2024, at a CAGR of 13.2% between 2024 and 2029. Growth in this market is mainly driven by ... Read More
-
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033
... vaccines market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% during 2025-2033. The market is ... Read More
Research Assistance
